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the long-term outcome of STEMI and UAP.
METHODS The study enrolled 46 acute STEMI patients and 89 UAP
patients who accepted successful PCI, and 35 patients without CHD,
and followed up for 2 years. The MACE included cardiovascular death,
recurrent acute myocardial infarction (AMI), readmission for heart
failure or revascularization.
RESULTS The plasma catestatin level in STEMI group (0.800.62
ng/ml) and in UAP group (0.990.62 ng/ml) were signiﬁcantly lower
than that of control group (1.380.98 ng/ml) (p ¼0.001). There were 7
MACEs (readmission for revascularization) in the UAP group, and
there were 8 MACEs (2 recurrent AMI, 3 readmission for revasculari-
zation, and 3 readmission for heart failure) in STEMI group including,
during 2 years follow up after discharge. There were no signiﬁcant
differences between STEMI group and UAP group. The MACEs
occurred at median 13.5 months after discharge. Kaplan – Meier haz-
ard analyses showed that there were no signiﬁcant differences in
MACE between the patients with high level catestatin and low level
catestatin (p¼0.587). In the Cox proportional hazards regression, LVEF
was the only independent predictor for MACE (HR 0.95, p ¼0.029),
catestatin level was not independently associated with MACE.
CONCLUSIONS The plasma catestatin levels in STEMI and UAP pa-
tients were lower than that in the patients without CHD. The catestatin
levels were not related to the MACE among CHD patients. An early
deﬁciency of catestatin might play a pathogenic role in the subsequent
development of acute coronary syndrome. Catestatin is thus emerging
as a very important peptide regulating multiple functions, and iden-
tiﬁcation of the molecular mechanism underlying the protective role
of this peptide may lead to a novel therapeutic option in CHD.
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The relationship between the composite index of the serum bilirubin and
serum lipid variables and the serum ﬁbrinogen level and the severity of
coronary heart disease
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Department of Cardiology, Afﬁliated Hospital of XuZhou Medical
College, Xuzhou, China
OBJECTIVES To explore the relationship between the composite in-
dex of the serum bilirubin and serum lipid variables, the serum
ﬁbrinogen(FIB) level and the severity of coronary heart disease. To
investigate whether it is more signiﬁcant for the composite index of
the serum bilirubin and serum lipid variables to predict coronary than
the traditional serum lipid variables, like cholesterol(TC) and low
density lipoprotein cholesterol(LDL-C).
METHODS A total of 324 patients who had undergone coronary
angiography were collected. They were divided into two groups by
their results of coronary angiography :①the group of coronary ar-
tery disease(CAD);②normal. The GENSINI scoring system were used
for determining the severity of coronary artery disease. All of the
patients were divided to 4 groups depending on its results: group
A: <P25; group B:P25-P50; group C:P50-P75 and group D: >P75. The
levels of serum total bilirubin(TBIL), cholesterol(TC), low density
lipoprotein cholesterol(LDL-C), high density lipoprotein cholester-
ol(HDL-C) and ﬁbrinogen(FIB) were measured, at the same time, the
ratio value of TC/(HDL-CþTBIL) and LDL-C/(HDL-CþTBIL) were
calculated.
RESULTS The results of TC, LDL-C, FIB, TC/(HDL-CþTBIL), LDL-C/
(HDL-CþTBIL) has shown signiﬁcant differences (P<0.05) between
CAD group and normal group. Signiﬁcant difference(P<0.05) has
shown in the FIB levels and LDL-C/(HDL-CþTBIL) ratio, TC/(HDL-
CþTBIL) ratio and HDL-C levels, TBIL levels and IBIL levels among
group A, B, C and D. Bivariate analysis shows that the results of TC,
FIB, LDL-C/(HDL-CþTBIL) ratio, TC/(HDL-CþTBIL) ratio positively
correlated with GENSINI score, HDL-C, TBIL and IBIL levels negatively
correlated with the GENSINI score; what’s more, the results showed
that the TBIL levels negatively correlated with the TG levels and LDL-
C levels, simultaneously, the DBIL levels negatively correlated with
the TC and TG levels. The area under the ROC curve of LDL-C/(HDL-
CþTBIL) was 0.801 and the 95% conﬁdence interval of the corre-
sponding area was 0.745-0858. If the pivotal point of diagnosis of CAD
was 0.1643, the speciﬁcity was 81.0%, and the sensitivity was 61.7%.
The area under the ROC curve of TC/(HDL-CþTBIL) was 0.805 and the
95% conﬁdence interval of the corresponding area was 0.751-0.860. If
the pivotal point of diagnosis of CAD was 0.2930, the speciﬁcity was
81.0%, and the sensitivity was 65.6%.CONCLUSIONS The composite index of the serum bilirubin and
serum lipid variables and the serum ﬁbrinogen(FIB) level positively
correlated with the severity of coronary heart disease. Using the
composite index of the serum bilirubin and serum lipid variables to
predict the severity of coronary atherosclerosis is better than tradi-
tional serum lipid variables do.GW26-e1444
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OBJECTIVES This study was to evaluate the association between
atherosclerotic plaque characteristics (APCs) by coronary computed
tomography angiography (CTA), and lesion ischemia by fractional ﬂow
reserve (FFR).
METHODS 252 patients (mean age 63 years; 71% males) underwent
coronary CTA, with FFR performed for 407 coronary lesions. Coronary
CTA was interpreted for <50% and 50% stenosis, with the latter
considered obstructive. APCs by coronary CTA were deﬁned as:
1) positive remodeling (PR), lesion diameter/reference diameter >1.10;
2) low attenuation plaque (LAP), any voxel <30 Hounsﬁeld units; and
3) spotty calciﬁcation (SC), nodular calciﬁed plaque <3 mm. Odds
ratios (OR) and net reclassiﬁcation improvement of APCs for lesion
ischemia, deﬁned by FFR 0.8, were analyzed.
RESULTS By FFR, ischemia was present in 151 lesions (37%). Aggregate
plaque volume (APV) was associated with a 50% increased risk of
ischemia per 5% additional APV. PR, LAP, and SC were associated with
ischemia, with a 3 to 5 times higher prevalence than in nonischemic le-
sions. In multivariable analyses, a stepwise increased risk of ischemia was
observed for 1 (OR: 4.0, p < 0.001) and 2 (OR: 12.1, p < 0.001) APCs.
These ﬁndings were APC dependent, with PR (OR: 5.3, p < 0.001) and
LAP (OR: 2.1, p ¼ 0.038) associated with ischemia, but not SC. When
examined by stenosis severity, PR remained a predictor of ischemia for all
lesions, whereas APV and LAP were associated with ischemia for
only 50%, but not for <50%, stenosis.
CONCLUSIONS APV and APCs by coronary CTA improve identiﬁcation
of coronary lesions that cause ischemia. PR is associated with all
ischemia-causing lesions, whereas APV and LAP are only associated
with ischemia-causing lesions 50%.GW26-e2105
Polymorphisms in the MAFB gene are associated with the risk of coronary
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OBJECTIVES MAFB has been associated with serum lipid levels in
the European population. However, little is known about such
association in the Chinese population or in atherosclerosis-related
patients. Therefore, the purpose of the present study was to
assess the association of the single nucleotide polymorphisms
(SNPs) in the MAFB and serum lipid levels and the risk of coro-
nary artery disease (CAD) and ischemic stroke (IS) in the Chinese
population.
METHODS A total of 1,065 unrelated patients (CAD, 525 and IS,
540) and 539 healthy controls were recruited in this study. Coro-
nary angiography was performed in patients with CAD. CAD was
deﬁned as signiﬁcant coronary stenosis (>50%) in at least either
one of the three main coronary arteries or their major branches
(branch diameter >2 mm). The classiﬁcation of IS was made ac-
cording to the TOAST (Trial of Org 10172 in Acute Stroke Treat-
ment) criteria. The selected IS patients in the study included
individuals who were eligible for one of the two subtypes of
TOAST criteria: Large-artery atherosclerosis and small-vessel oc-
clusion. Subjects with a history of hematologic, neoplastic, renal,
liver, thyroid, autoimmune diseases and type I diabetes mellitus
were excluded. The selected IS patients who had a past history of
CAD were excluded, while the selected CAD patients who had a
past history of IS were excluded from the study. Genotypes of the
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Snapshot technology platform.
RESULTS The AA genotype of rs2902940 SNP was associated with
an increased risk of CAD (adjusted OR ¼ 1.63, 95% CI ¼ 1.07-2.48,
P ¼ 0.023) and IS (adjusted OR ¼ 1.69, 95% CI ¼ 1.09-2.61, P ¼
0.017). The GA/AA genotype was also associated with an increased
risk of CAD (adjusted OR ¼ 1.56, 95% CI ¼ 1.04-2.32, P ¼ 0.030
for GA/AA vs. GG) and IS (adjusted OR ¼ 1.72, 95% CI ¼ 1.14-2.60,
P ¼ 0.010 for GA/AA vs. GG). Signiﬁcant interactions were
observed only in those with higher BMI, hypertension and dia-
betes (P<0.05). The subjects with GA/AA genotypes in controls
had lower serum ApoAI levels than the subjects with GG genotype
(P ¼ 0.024).
CONCLUSIONS The A allele carriers of SNP rs2902940 in the MAFB
conferred a decreased serum ApoAI levels in controls and an
increased risk of CAD and IS. The GA/AA genotypes interacted with
higher BMI, hypertension and diabetes to contribute the risk of CAD
and IS.
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OBJECTIVES This multiple-ethnic, community-based, cross-sectional
study was conducted to estimate the prevalence and distribution of
congenital heart disease (CHD) in Xinjiang, northwestern part of
China. Four major ethnics, Han, Uygur, Kazakh, and Hui Chinese in
this region were investigated during February 2010 and May 2012.
METHODS A total of 14,530 children (0-18 yr) completed the survey
and were examined. Those suspected of having the CHD were further
evaluated with electrocardiograph (ECG) and the diagnosis was
conﬁrmed by echocardiography.
RESULTS Of these children, 240 (boys, 43.8% and girls, 56.3%) were
identiﬁed with CHD, giving an overall prevalence of 16.5& (17.7& in
Uygur, 6.9& in Han, 11.4& in Kazak, and 38.1& in Hui Chinese,
respectively). Ventricular septal defect (VSD, 29.2%), atrial septal
defect (ASD, 20.8%), patent ductus arteriosus (PDA, 13.7%), acleisto-
cardia (13.7%), Bicuspid aortic valve (7.9%), pulmonary valve stenosis
(5.4%), tetralogy of fallot (TOF, 4.2%) were common acynotic and
cyanotic defects observed. Further, among these CHD children, 27.1%
mothers had a history of abortion, and 24% caught a cold, 10% had a
febrile illness and 6.7% received antibiotic treatment during the ﬁrst
trimester of pregnancy. The highest incidence of CHD in Hui children
at 0-6 yrs group was observed with the highest percentage of CHD
family history and consanguinity.
CONCLUSIONS The overall prevalence of CHD in four ethnical chil-
dren at age of 0-18 yr in Xinjiang was 16.5&. VSD, ASD and TOF were
the most common acyanotic and cyanotic congenital heart defects,
respectively. This study also investigated some modiﬁable risk factor
which may link to the difference in the incidence of CHD among the 4
ethnical groups.
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OBJECTIVES To study the immediate effect of injecting ATP and
nitroglycerin into coronary artery on treating Coronary Slow Flow
Angina(CSFA).
METHODS 56 patients, complaining the Angina symptom, without
stenotic lesions of epicardial major arteries and with slow ﬂow in
anterior descending branch (LAD), both of which veriﬁed by coronary
angiography, were chosen among 2842 patients undergoing coronary
angiography between May,2009 and Dec,2011. They were assigned to
ATP (31) and nitroglycerin (25), Control group (34, patients withmatched age, gender, cardiovascular risk factor and normal coronary
angiography). In the ATP group, coronary angiography was re-per-
formed after quickly injecting ATP 40ug into coronary by angio-
graphic catheter. In the nitroglycerin group, patients were dealt with
nitroglycerin 200ug. The coronary blood ﬂow was measured by TIMI
Frame Count (TFI). Obtain TFC values which recorded in liver position
in LAD slow-ﬂowing patients before and after the treatment and in
normal patients.
RESULTS 1. Basic TFC value was 76.320.6 in the ATP group,
73.818.3 in the nitroglycerin group and 28.72.6 in the control group.
2. TFC value was reduced to 26.33.2 in the ATP group after the
treatment(Compared to the value before the treatment, P <0.01.
Compared to the control group, there was no signiﬁcant difference.).
The value was reduced to 48.68.2in the nitroglycerin group after the
treatment (Compared to the value before the treatment, P <0.01. The
value was above the level of the control group, P<0.05.). The TFC
value before and after ATP treatment was obviously higher than the
nitroglycerin group (P <0.05). 3. For the 15 patients in the nitroglyc-
erin group, mean TFC value was 56.66.2, after another treatment-
injecting ATP 40ug, TFC value was reduced to 26.64.7 (In contrast to
nitroglycerin treatment, P <0.01. Compared to the control group, P
>0.05, no signiﬁcant difference).
CONCLUSIONS After ATP injection, the immediate coronary ﬂow was
normalized in patients with CSFA, superior to nitroglycerin treatment.
For the poor recovery patients after nitroglycerin treatment, giving
ATP could make coronary ﬂow reach to normal level. Obviously, the
major pathologic change of myocardial ischemia caused by CSFA was
located in microvessel.
GW26-e3583
Correlation between platelet parameters, hypersensitive C-reactive
protein and clopidogrel reactivity in unstable angina patients
Xiaolu Chen, Xianghua Fu
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OBJECTIVES Unstable angina is a severe type of coronary heart dis-
ease (CHD). Dual antiplatelet therapy with aspirin and clopidogrel was
established as a cornerstone of therapy in patients with unstable
angina(UA) and stent implantation. Platelet inhibition by clopidogrel
varies from one individual to the next. We refer those treated with
clopidogrel had minimal or no alternation in platelet function as
clopidogrel resistance (CR) or high on-treatment platelet reac-
tivity(HTPR). CR is considered a failure of antiplatelet treatment.
Patients who have CR are at increased risk of major adverse cardiac
events. Recent studies have identiﬁed numerous inﬂuencing factors
for the antiplatelet effect of clopidogrel. The aim of this study was to
explore the association between platelet parameters, hs-CRP and
clopidogrel resistance.
METHODS A total of 124 unstable angina patients were enrolled in this
study from November 2013 to January 2014, in the second hospital of
Hebei Medical University. All patients had not taken aspirin or clo-
pidogrel that affect platelet function. Blood routine test, coagulation
routine test, myocardial enzyme, hepatic function, renal function,
plasma lipid, platelet aggregation rate(PAR0) were checked within one
day. A loading dose of 300mg clopidogrel and 300mg aspirin were
given to all the patients, and 75mg/d clopidogrel and 100mg/d aspirin
were maintained. Platelet aggregation rate was remeasured at 7th
day(PAR1). According to the degree of platelet aggregation inhibition
[DPAI, DPAI¼(PAR0-PAR1)/PAR0], all patients were divided into clo-
pidogrel resistance group(CR) and clopidogrel sensitive group(CS).
There were 33 cases(19 males and 14 females) in CR group, the mean
age was 61.91, while there were 91 cases(49 males and 42 females) in
CS group, and the mean age was 62.40. Platelet parameters including
platelet count(PLT), mean platelet volume(MPV), platelet distribution
width(PDW) and hypersensitive C-reactive protein(hs-CRP) levels
were compared between the two groups.
RESULTS 1. Baseline clinical characteristics: There was no signiﬁcant
difference between CR group and CS group in age, gender, BMI, his-
tory of hypertension, history of diabetes mellitus, smoking history
and drinking history.
2. Platelet parameters and hs-CRP level: The PLT, PDW, PCT levels
had no signiﬁcant difference between the CR group and the CS group.
The MPV level was signiﬁcant higher in the CR group than that of CS
group(9.311.00ﬂ vs. 8.480.96ﬂ, P<0.05). And the hs-CRP level was
signiﬁcant higher in the CR group than that of CS group(6.624.30 vs.
3.383.18, P<0.05).
